| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.58▼ | 1.59▼ | 1.58▼ | 1.55▲ | 1.57▼ |
| MA10 | 1.59▼ | 1.57▼ | 1.59▼ | 1.55▲ | 1.85▼ |
| MA20 | 1.60▼ | 1.61▼ | 1.58▼ | 1.60▼ | 2.07▼ |
| MA50 | 1.57▼ | 1.55▲ | 1.54▲ | 1.93▼ | 1.89▼ |
| MA100 | 1.61▼ | 1.54▲ | 1.56▲ | 2.08▼ | 1.95▼ |
| MA200 | 1.55▲ | 1.57▼ | 1.71▼ | 1.93▼ | 2.13▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.005▼ | -0.005▼ | -0.006▼ | 0.022▲ | -0.100▼ |
| RSI | 44.668▼ | 47.556▼ | 50.011▲ | 43.581▼ | 37.181▼ |
| STOCH | 28.308 | 69.477 | 19.007▼ | 40.882 | 7.441▼ |
| WILL %R | -83.333▼ | -58.824 | -81.081▼ | -52.542 | -88.136▼ |
| CCI | -153.026▼ | 17.704 | -47.367 | 29.483 | -90.858 |
|
Tuesday, November 10, 2026 05:30 AM
Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing IKT-001, a novel once-daily oral anti-proliferative for Pulmonary Arterial Hypertension (“PAH”), ...
|
|
Friday, October 02, 2026 09:01 AM
WILMINGTON, Del., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), today announced that the Company granted non-qualified stock options to ...
|
|
Monday, June 29, 2026 05:01 PM
Short interest in Inhibikase Therapeutics Inc (NASDAQ:IKT) increased during the last reporting period, rising from 18.89M to 19.42M. This put 23.66% of the company's publicly available shares short.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/11/26 | 1.615 | 1.615 | 1.56 | 1.57 | 6,704 |
| 10/11/26 | 1.65 | 1.65 | 1.53 | 1.55 | 483,851 |
| 09/11/26 | 1.54 | 1.725 | 1.51 | 1.68 | 558,728 |
| 06/11/26 | 1.44 | 1.53 | 1.44 | 1.50 | 356,013 |
| 05/11/26 | 1.56 | 1.56 | 1.43 | 1.44 | 742,652 |
| 04/11/26 | 1.56 | 1.60 | 1.51 | 1.565 | 675,400 |
| 03/11/26 | 1.57 | 1.59 | 1.47 | 1.48 | 600,673 |
| 02/11/26 | 1.56 | 1.59 | 1.47 | 1.54 | 449,231 |
| 30/10/26 | 1.67 | 1.67 | 1.52 | 1.55 | 437,986 |
| 29/10/26 | 1.64 | 1.695 | 1.625 | 1.67 | 852,337 |
|
|
||||
|
|
||||
|
|